Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), HilleVax, Inc (HLVX) and Cabaletta Bio (CABA)
TipRanksMar 26 10:10
Stifel Adjusts HilleVax Price Target to $34 From $30, Maintains Buy Rating
MT NewswiresMar 22 00:07
HilleVax Analyst Ratings
BenzingaMar 21 18:24
HilleVax, Inc's HIL-214 Vaccine Candidate Promises Broad Protection Against Norovirus, Justifying Buy Rating
TipRanksMar 21 18:16
HilleVax Analyst Ratings
BenzingaDec 13, 2023 19:23
Guggenheim Maintains Buy on HilleVax, Lowers Price Target to $34
BenzingaNov 16, 2023 03:02
HilleVax Analyst Ratings
BenzingaNov 16, 2023 03:01
Positive Financial Outlook and High Probability of Success Bolster Buy Rating for HilleVax, Inc: An Analyst Recommendation Report
TipRanksNov 14, 2023 14:58
Stifel Maintains Buy on HilleVax, Lowers Price Target to $30
BenzingaNov 11, 2023 04:26
HilleVax Analyst Ratings
BenzingaNov 11, 2023 04:25
SVB Securities Remains a Buy on HilleVax, Inc (HLVX)
TipRanksJun 3, 2023 20:55
HilleVax, Inc (HLVX) Receives a Buy From SVB Securities
TipRanksMay 17, 2023 08:35
J.P. Morgan Keeps Their Buy Rating on HilleVax, Inc (HLVX)
TipRanksMay 17, 2023 00:25
JPMorgan Adjusts Price Target on HilleVax to $22 From $23, Maintains Overweight Rating
MT NewswiresMay 16, 2023 20:44
HilleVax, Inc (HLVX) Gets a Buy From SVB Securities
TipRanksApr 27, 2023 20:57
SVB Securities Reaffirms Their Buy Rating on HilleVax, Inc (HLVX)
TipRanksNov 14, 2022 12:00
No Data
No Data